About Bioprinting & Medical
The Bioprinting & Medical category is part of the 3D Printing & Additive Manufacturing market map, tracking 12 companies building in this segment. Metal and polymer printing, bioprinting, on-demand production, and AI-driven design optimization reshaping how physical objects get made. Curated by Hartmann Capital's venture research team.
Companies in Bioprinting & Medical
- CELLINK — Public
- Organovo — Public, $5.3M
- Aspect Biosystems — Series B, $139M
- BICO Group — Public
- CollPlant — Public
- Rokit Healthcare — Public
- Allevi — Acquired
- Prellis Biologics — Series A, $10.5M
- Regemat 3D — Seed
- Axolotl Biosciences — Seed
- Particle3D — Seed, $3.6M
- Dimension Inx — Seed, $3.6M
Frequently Asked Questions
- What companies are in the Bioprinting & Medical category?
- The Bioprinting & Medical category includes 12 companies: CELLINK, Organovo, Aspect Biosystems, BICO Group, CollPlant, Rokit Healthcare, Allevi, Prellis Biologics, Regemat 3D, Axolotl Biosciences, Particle3D, Dimension Inx. This is part of the 3D Printing & Additive Manufacturing market map maintained by Hartmann Capital.
- How many Bioprinting & Medical startups are tracked?
- Hartmann Capital tracks 12 companies in the Bioprinting & Medical segment of the 3D Printing & Additive Manufacturing market map.
- What are the best funded Bioprinting & Medical companies?
- Top funded companies in Bioprinting & Medical include Aspect Biosystems ($139M), Prellis Biologics ($10.5M), Organovo ($5.25M), Particle3D ($3.6M), Dimension Inx ($3.6M). Browse the full list in the 3D Printing & Additive Manufacturing market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.